JIP
JAZZ icon

Jaffetilchin Investment Partners’s Jazz Pharmaceuticals JAZZ Stock Holding History

Jaffetilchin Investment Partners’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-11
Closed -$1.23K – 839
2024
Q3 		$1.23K Buy
+11
New +$1.21K ﹤0.01% 1227
2017
Q4 		– Sell
-5,607
Closed -$820K – 266
2017
Q3 		$820K Sell
5,607
-3,952
-41% -$598K 0.19% 94
2017
Q2 		$1.49M Buy
+9,559
New +$1.46M 0.5% 32
2016
Q3 		– Sell
-2,486
Closed -$351K – 249
2016
Q2 		$351K Buy
+2,486
New +$366K 0.11% 159
2014
Q2 		– Sell
-2,314
Closed -$321K – 220
2014
Q1 		$321K Buy
+2,314
New +$348K 0.13% 145

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Jaffetilchin Investment Partners's JAZZ Position: Q4 2024 in Review

Jaffetilchin Investment Partners sold out of Jazz Pharmaceuticals (JAZZ) in Q4 2024, closing a stake of 11 shares — an estimated $1.23K sold.

Jaffetilchin Investment Partners first reported a position in JAZZ in Q1 2014 and held it in 5 quarters. The position peaked at $1.49M in Q2 2017. 508 funds tracked by Wall St. Rank hold JAZZ as of Q4 2024.

  • Jaffetilchin Investment Partners reported no remaining Jazz Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Jaffetilchin Investment Partners sold 11 Jazz Pharmaceuticals shares in Q4 2024, an estimated $1.23K.
  • Jaffetilchin Investment Partners first reported a position in Jazz Pharmaceuticals in Q1 2014 and held it in 5 quarters.
  • Jaffetilchin Investment Partners's Jazz Pharmaceuticals position peaked at $1.49M in Q2 2017.
  • 508 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q4 2024.

Based on Jaffetilchin Investment Partners's 13F filing for Q4 2024, filed 13 Feb 2025.